Physician profile
Ryan Mcgowan
NPI 1508394453
$5,755.83
in general payments reported to CMS, 2019-2025
11 companies · $3,098 in 2025
The $3,098 reported for 2025 was more than what 86% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2023: $25.24 · 2024: $2,530 · 2025: $3,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,530 · Travel and Lodging: $2,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,530.31 |
| Travel and Lodging | $2,123.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,442.24 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $1,430.73 | 2023-2025 | Proclaim, Eterna |
| Stryker Corporation | $851.44 | 2024-2025 | Hoffmann, Mild Device Kit, Prostep Mica |
| Saluda Medical Americas, INC. | $600.58 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $407.90 | 2025 | General - Pain Management, Intracept |
| Mml US, INC. | $304.09 | 2025 | Reactiv8 |
| Nevro Corp. | $225.55 | 2024 | Senza |
| Globus Medical, INC. | $210.74 | 2025 | Senza |
| Averitas Pharma INC. | $127.46 | 2024 | Qutenza |
| Allergan, INC. | $102.16 | 2019 | |
| Spr Therapeutics, INC | $52.94 | 2024-2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcgowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.